CompletedNot Applicable

Zenith Alpha™ Abdominal Endovascular Graft

Canada100 participantsStarted 2017-05-24

Plain-language summary

The purpose of this study is to evaluate the clinical performance of the Zenith Alpha™ Abdominal Endovascular Graft for the treatment of abdominal aortic or aorto-iliac aneurysm.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * A patient is considered eligible for inclusion in the study if the patient has an infrarenal abdominal aortic or aorto-iliac aneurysm and is intended to be treated with the Zenith Alpha™ Abdominal Endovascular Graft Exclusion Criteria: * Life expectancy less than (\<) 2 years * Inability or refusal to give informed consent by the patient or legally authorized representative * Unwilling or unable to comply with the study follow-up

What they're measuring

Device Success

Timeframe: 2 years

Trial details

NCT IDNCT03061825

SponsorCook Research Incorporated

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2021-01-06

View on ClinicalTrials.gov More Abdominal Aortic trials